Mitch C. Hill - 12 Jan 2023 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Financial Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol: N/A
Transactions as of: 12 Jan 2023
Net transactions value: -$839,043
Form type: 4
Filing time: 13 Jan 2023, 15:50:00 UTC
Previous filing: 04 Jan 2023
Next filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$2,970	+6,500	+11%	$0.4570^*	65,204	12 Jan 2023	Direct	F1
transaction	NARI	Common Stock	Sale	$281,013	-4,287	-6.6%	$65.55	60,917	12 Jan 2023	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$146,611	-2,213	-3.6%	$66.25	58,704	12 Jan 2023	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$233,537	-3,515	-6%	$66.44	55,189	12 Jan 2023	Direct	F1, F4
transaction	NARI	Common Stock	Sale	$174,174	-2,635	-4.8%	$66.10	52,554	12 Jan 2023	Direct	F1, F5
transaction	NARI	Common Stock	Sale	$6,679	-100	-0.19%	$66.79	52,454	12 Jan 2023	Direct	F1
holding	NARI	Common Stock						1,600	12 Jan 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to Buy)	Options Exercise	$0	-6,500	-3.8%	$0.000000	165,977	12 Jan 2023	Common Stock	6,500	$0.4570	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2	This transaction was executed in multiple trades at prices ranging from $64.96 to $65.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $65.96 to $66.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $64.78 to $65.72 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	This transaction was executed in multiple trades at prices ranging from $65.79 to $66.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6	Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.